Literature DB >> 16984376

Lack of enhancement of susceptibility to mammary and thyroid carcinogenesis in rats exposed to DMBA and DHPN following prepubertal iodine deficiency.

Young-Man Cho1, Toshio Imai, Mai Hasumura, Masao Hirose.   

Abstract

Epidemiologic and experimental studies suggest that iodine deficiency increases the risk of mammary as well as thyroid cancers, but susceptibility to tumor development when this occurs during the prepubertal stage is not completely understood. In the present study, we therefore evaluated this question in F344 rats. Dams during the lactation period and their weaned offspring until postnatal week 7 were fed an iodine-free diet. Female offspring were then given 7,12-dimethylbenz[a]anthracene (DMBA, 50 mg/kg body weight) by gavage for mammary tumor induction in week 7. Both the male and female rats were given free access to drinking water containing N-bis(2-hydroxypropyl)nitrosamine (DHPN), (0.1 and 0.2% for male and female rats, respectively) for wide spectrum tumor induction in organs, including the thyroid gland, from weeks 7-11. All offspring were killed at week 50 for histopathological examination. The iodine deficiency had no significant influence on incidences and/or multiplicities of mammary and thyroid tumors. Furthermore, tumor induction in the liver, kidney, lung, esophagus and urinary bladder was not affected in either sex. The present results thus indicate a lack of influence of iodine deficiency condition early in life on subsequent carcinogenic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984376     DOI: 10.1111/j.1349-7006.2006.00303.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  2 in total

1.  Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.

Authors:  Michael B Zimmermann; Valeria Galetti
Journal:  Thyroid Res       Date:  2015-06-18

2.  The correlation between breast cancer and urinary iodine excretion levels.

Authors:  Fatma Umit Malya; Huseyin Kadioglu; Mustafa Hasbahceci; Kemal Dolay; Mehmet Guzel; Yeliz Emine Ersoy
Journal:  J Int Med Res       Date:  2017-08-31       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.